BCL11a degrader (Coloma Therapeutics)

N/A

Report date: 2025/06/11 11:11:53
NME

Base Information

Drug NameBCL11a degrader (Coloma Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionB-cell lymphoma/leukemia 11A degraders
TargetsB-cell lymphoma/leukemia 11A
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesColoma Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesColoma Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A